Business, energy, technology, markets and global industry news from Business News Today

neurovascular devices

PharmaDeviceNews neurovascular devices
Representative image of a neurovascular intervention setting, highlighting how Medtronic’s Scientia Vascular acquisition could strengthen access technology for stroke and aneurysm care.
Medical Devices & Diagnostics

Why Medtronic’s Scientia Vascular acquisition matters for stroke device workflows

Find out how Medtronic’s Scientia Vascular acquisition could reshape neurovascular access, stroke workflows and medtech competition.

Read More
Representative image of neurovascular stroke intervention as Penumbra’s THUNDERBOLT FDA clearance puts computer assisted vacuum thrombectomy, acute ischemic stroke care, and clot removal technology under sharper focus.
Medical Devices & Diagnostics

Penumbra’s THUNDERBOLT clearance strengthens Boston Scientific’s pending vascular device bet

Find out how Penumbra’s THUNDERBOLT FDA clearance could reshape stroke thrombectomy, CAVT adoption, and medtech competition.

Read More
Representative image of an advanced neurovascular stroke procedure, illustrating how Rapid Medical’s TIGERTRIEVER 13 DISTALS trial data could support wider interest in small-vessel thrombectomy for distal and medium vessel occlusion stroke.
Medical Devices & Diagnostics

Why Rapid Medical’s DISTALS data could reshape treatment expectations in smaller stroke vessels

Distal stroke has long lacked device options. Rapid Medical’s TIGERTRIEVER 13 data now tests whether small-vessel thrombectomy can scale.

Read More
Medtronic’s $550 million Scientia Vascular purchase signals a strategic shift in neurovascular procedure access
Medical Devices & Diagnostics

Can Medtronic’s $550m Scientia Vascular deal improve catheter and guidewire technology for stroke treatment?

Medtronic plans to acquire Scientia Vascular for $550M. Explore what the deal changes for stroke intervention devices and neurovascular procedure access.

Read More
Medical Devices & Diagnostics

Can CereVasc’s eShunt system change the future of idiopathic intracranial hypertension treatment?

CereVasc’s eShunt system shows three-year outcomes in idiopathic intracranial hypertension. Discover what this means for future brain pressure treatments.

Read More
Representative image showing an endovascular thrombectomy procedure used in stroke care, reflecting growing clinical interest in distal and medium vessel occlusion treatment following recent trial data.
Medical Devices & Diagnostics

Rapid Medical’s DISTALS trial signals a structural shift in how medium vessel stroke may finally be treated

Rapid Medical disclosed late-breaking results from its DISTALS randomized controlled trial showing that the TIGERTRIEVER 13 thrombectomy device achieved significantly higher tissue reperfusion without symptomatic intracranial hemorrhage compared with medical management in medium vessel occlusion stroke. The data were presented at the 2026 International Stroke Conference and form the basis for a planned United States

Read More
Medical Devices & Diagnostics

Could CereVasc’s eShunt replace VP shunts in post-aneurysmal hydrocephalus treatment?

CereVasc completes ETCHES trial enrollment for its eShunt device in post-SAH hydrocephalus. Learn what this means for future neurosurgical care.

Read More